文献速递神经肿瘤

放射性脑肿瘤的特征:病例系列与系统综述

Characteristics of radiation-induced brain tumors: case series and systematic review.
PubMed 文献 · J Neurosurg · 2024-06-07

本研究纳入16例病例系列和941例文献报道的颅脑照射后发生放射性脑肿瘤的患者,分析潜伏期和总生存期。脑膜瘤潜伏期20年长于胶质瘤9年和肉瘤10年,总生存期脑膜瘤未达到而胶质瘤和肉瘤均为11个月,高剂量照射者预后更差。

要点

  • 23.4%的放射性脑肿瘤患者在5岁前接受照射,46.6%在第一个十年内接受照射。
  • 脑膜瘤中位潜伏期20年显著长于胶质瘤9年和肉瘤10年(p<0.0001)。
  • 脑膜瘤总生存期未达到,显著长于胶质瘤11个月和肉瘤11个月(p<0.0001)。

核心结论

  • 放射性脑肿瘤患者预后差,胶质瘤和肉瘤患者预后较脑膜瘤更差,原发病接受更高剂量照射的放射性脑肿瘤患者预后更差。
  • 由于放射性脑肿瘤在颅脑照射后超过十年才发生,长期随访至关重要。

研究设计与样本

  • 病例系列纳入16例患者,文献纳入941例既往接受颅脑照射的患者。
  • 采用Kaplan-Meier法分析潜伏期和总生存期,按照射时年龄(儿童与非儿童)和照射剂量(高剂量与低剂量)分层,采用log-rank检验比较。

主要发现

  • 放射性脑肿瘤患者中,23.4%在5岁前接受照射,46.6%在第一个十年内接受照射。
  • 脑膜瘤、胶质瘤和肉瘤患者接受颅脑照射的中位年龄分别为8.4岁(IQR 4.1-16)、9岁(IQR 5-23)和27.7岁(IQR 13.8-40)。
  • 脑膜瘤中位潜伏期20年,显著长于胶质瘤9年和肉瘤10年(p<0.0001)。
  • 非儿童组脑膜瘤患者潜伏期更短(p=0.047)。
  • 脑膜瘤总生存期未达到,显著长于胶质瘤11个月和肉瘤11个月(p<0.0001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Radiation therapy (RT) improves the outcome of patients with cancer but introduces the risk of radiation-induced neoplasms in cancer survivors. The most common radiation-induced brain tumors (RIBTs) are gliomas (RIGs), meningiomas (RIMs), and sarcomas (RISs). To investigate the characteristics of these RIBTs, the authors conducted a comprehensive review and analysis of their case series and relevant cases from the literature. METHODS: Sixteen patients in the case series and 941 patients from the literature who previously underwent cranial irradiation were included in this study. The age at irradiation for primary disease was recorded, and the latency period from irradiation to the development of RIBT and the median overall survival (OS) of patients with RIBTs were analyzed using the Kaplan-Meier method. Patients were stratified by age at the time of irradiation (pediatric vs nonpediatric) and the irradiation dose (higher vs lower dose), and latency and OS were compared using the log-rank test. RESULTS: Among patients with RIBTs, 23.4% underwent radiation at < 5 years of age, and 46.6% underwent RT in the 1st decade of life. The median ages at cranial irradiation were 8.4 (IQR 4.1-16) years in patients with RIMs, 9 (IQR 5-23) years in patients with RIGs, and 27.7 (IQR 13.8-40) years in patients with RISs. The median latency period from irradiation to the development of RIM was significantly longer than that to the development of RIG and RIS (RIM: 20 years, RIG: 9 years, RIS: 10 years; p < 0.0001). The latency period was shorter in the nonpediatric patient group with RIMs (p = 0.047). The OS was significantly longer in patients with RIMs than in those with RIGs and RISs (RIM: not reached, RIG: 11 months, RIS: 11 months; p < 0.0001). The OS of patients with RIMs and RIGs was significantly shorter in patients who received higher radiation doses (p = 0.0095 and p = 0.0026, respectively). CONCLUSIONS: The prognosis was poor and worse for patients with RIGs and RISs than for those with RIMs, and patients with RIBTs who underwent higher-dose irradiation for primary disease had poor prognoses. Because RIBTs develop more than a decade after cranial irradiation, long-term follow-up is crucial.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Onishi S, Yamasaki F, Kinoshita Y, et al. Characteristics of radiation-induced brain tumors: case series and systematic review. J Neurosurg. 2024. PMID: 38848603. doi:10.3171/2024.3.JNS232934

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。